Outcomes After Weight Loss Surgery in Low-Risk Patients
Launched by DR. FEIZ & ASSOCIATES · Jan 24, 2023
Trial Information
Current as of November 06, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how weight loss surgery affects people who have a lower body weight and no serious health problems. Specifically, it focuses on patients with a body mass index (BMI) between 30 and 34.5, which means they are slightly overweight but do not have conditions like diabetes or high blood pressure. The researchers want to hear from these patients about how their health, mood, quality of life, and overall happiness improve after the surgery.
To participate in this study, individuals must be medically cleared for surgery and provide consent, meaning they agree to take part and understand what it involves. Those who are pregnant, have a BMI below 30 or above 34.5, or have any serious health issues will not be eligible. If you qualify and choose to join, you can expect to share your experiences and feelings before and after the surgery, helping to fill in a gap in our understanding of outcomes for low-risk patients undergoing weight loss surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with BMI between 30 kg/m2 and 34.5 kg/m2 without co-morbidities who are medically cleared to undergo cosmetic weight loss surgery.
- • Written informed consent obtained from the subject or the subject's legal representative and the ability for the subject to comply with the requirements of the study.
- Exclusion Criteria:
- • Patients who are pregnant.
- • Patients with BMI below 30 kg/m2.
- • Patients with BMI above 34.5 kg/m2.
- • Patients who have co-morbidities including, but not limited to, diabetes mellitus, hypertension, sleep apnea, and degenerative joint disease.
- • Patients who are not medically cleared to undergo weight loss surgery.
About Dr. Feiz & Associates
Dr. Feiz & Associates is a leading clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative studies. With a focus on surgical interventions and minimally invasive techniques, the organization combines expert clinical leadership with a commitment to ethical research practices. Dr. Feiz & Associates collaborates with a network of healthcare professionals and institutions to conduct rigorous trials that adhere to the highest standards of scientific integrity. Their mission is to enhance the understanding of treatment efficacy and safety, ultimately contributing to the development of groundbreaking therapies in the field of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beverly Hills, California, United States
Patients applied
Trial Officials
Michael Feizbakhsh, MD
Principal Investigator
Dr. Feiz and Associates
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials